Literature DB >> 25532003

The use of mebeverine in irritable bowel syndrome. A Position paper of the Romanian Society of Neurogastroenterology based on evidence.

Dan L Dumitrascu1, Alexandra Chira2, Simona Bataga3, Mircea Diculescu4, Vasile Drug5, Cristian Gheorghe4, Adrian Goldis6, Laurentiu Nedelcu7, Paul J Porr8, Ioan Sporea6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25532003     DOI： 10.15403/jgld.2014.1121.234.mibs

Source DB:  PubMed          Journal:  J Gastrointestin Liver Dis        ISSN： 1841-8724            Impact factor:   2.008


× No keyword cloud information.
  1 in total

1.  Will controlled release mebeverine be able to surpass placebo in treatment of diarrhoea predominant irritable bowel syndrome?

Authors:  Dwaipayan Sarathi Chakraborty; Avijit Hazra; Amrita Sil; Shantasil Pain
Journal:  J Family Med Prim Care       Date:  2019-10-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.